Juntyma J. Engtrakul

Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections

Matthew F. Brown, Usa Reilly, J. A. Abramite et al. · Journal of Medicinal Chemistry · 2011 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections

Justin I. Montgomery, Matthew F. Brown, Usa Reilly et al. · Journal of Medicinal Chemistry · 2012 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

ALTERED AZT (3′-AZIDO-3′-DEOXYTHYMIDINE) GLUCURONIDATION KINETICS IN LIVER MICROSOMES AS AN EXPLANATION FOR UNDERPREDICTION OF IN VIVO CLEARANCE: COMPARISON TO HEPATOCYTES AND EFFECT OF INCUBATION ENVIRONMENT

Juntyma J. Engtrakul, R. Foti, Timothy J. Strelevitz et al. · Drug Metabolism and Disposition · 2005 · 68 citations

Pharmacy, Biochemistry, Pharmacokinetics +17

Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability

Todd Wisialowski, Kimberly Crimin, Juntyma J. Engtrakul et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 51 citations

Medicine, Cardiology, Pharmacology +17

Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV

Hardwin O’Dowd, Dean Shannon, Kishan R. Chandupatla et al. · ACS Medicinal Chemistry Letters · 2015 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17